PROTECT-TIMI 30 evaluated the angiographic efficacy of bivalirudin vs eptifibatide for coronary stenting. MAIN RESULTS: A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006 Jun 20;47(12):2364-73. PRESENTATIONS TIMI 30 Slides OTHER PUBLICATIONS Comparison of … Continue reading PROTECT-TIMI 30